NERV
Price
$1.71
Change
-$0.02 (-1.16%)
Updated
Apr 30, 04:49 PM (EDT)
Capitalization
12.06M
12 days until earnings call
RLFTY
Price
$3.00
Change
-$0.25 (-7.69%)
Updated
Apr 29 closing price
Capitalization
34.5M
Ad is loading...

NERV vs RLFTY

Header iconNERV vs RLFTY Comparison
Open Charts NERV vs RLFTYBanner chart's image
Minerva Neurosciences
Price$1.71
Change-$0.02 (-1.16%)
Volume$1K
Capitalization12.06M
RELIEF THERAPEUTICS HLDG AG
Price$3.00
Change-$0.25 (-7.69%)
Volume$1.56K
Capitalization34.5M
NERV vs RLFTY Comparison Chart
Loading...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NERV vs. RLFTY commentary
May 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NERV is a StrongBuy and RLFTY is a Hold.

Ad is loading...
COMPARISON
Comparison
May 01, 2025
Stock price -- (NERV: $1.73 vs. RLFTY: $3.00)
Brand notoriety: NERV and RLFTY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NERV: 81% vs. RLFTY: 397%
Market capitalization -- NERV: $12.06M vs. RLFTY: $34.5M
NERV [@Biotechnology] is valued at $12.06M. RLFTY’s [@Biotechnology] market capitalization is $34.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NERV’s FA Score shows that 0 FA rating(s) are green whileRLFTY’s FA Score has 1 green FA rating(s).

  • NERV’s FA Score: 0 green, 5 red.
  • RLFTY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLFTY is a better buy in the long-term than NERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NERV’s TA Score shows that 6 TA indicator(s) are bullish.

  • NERV’s TA Score: 6 bullish, 4 bearish.

Price Growth

NERV (@Biotechnology) experienced а +0.88% price change this week, while RLFTY (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.93%. For the same industry, the average monthly price growth was +3.53%, and the average quarterly price growth was -9.41%.

Reported Earning Dates

NERV is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+2.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLFTY($34.5M) has a higher market cap than NERV($12.1M). NERV YTD gains are higher at: -22.353 vs. RLFTY (-38.776). NERV has higher annual earnings (EBITDA): 6.02M vs. RLFTY (-48.16M). NERV has more cash in the bank: 21.4M vs. RLFTY (10.7M). NERV has less debt than RLFTY: NERV (0) vs RLFTY (2.42M). RLFTY has higher revenues than NERV: RLFTY (8.59M) vs NERV (0).
NERVRLFTYNERV / RLFTY
Capitalization12.1M34.5M35%
EBITDA6.02M-48.16M-13%
Gain YTD-22.353-38.77658%
P/E Ratio9.08N/A-
Revenue08.59M-
Total Cash21.4M10.7M200%
Total Debt02.42M-
FUNDAMENTALS RATINGS
NERV: Fundamental Ratings
NERV
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NERV
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HERO27.720.27
+0.98%
Global X Video Games & Esports ETF
KOCG28.320.17
+0.60%
FIS Knights of Columbus Global Blf ETF
DJUN41.610.14
+0.35%
FT Vest US Equity Deep Bfr ETF Jun
FNDF37.410.11
+0.29%
Schwab Fundamental International Eq ETF
BSJQ23.210.05
+0.20%
Invesco BulletShares 2026 HY Corp Bd ETF

NERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NERV has been loosely correlated with CVAC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then CVAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NERV
1D Price
Change %
NERV100%
-3.63%
CVAC - NERV
38%
Loosely correlated
+1.73%
GPCR - NERV
37%
Loosely correlated
+9.70%
DNLI - NERV
36%
Loosely correlated
+1.54%
AKRO - NERV
33%
Loosely correlated
+2.06%
ETNB - NERV
33%
Poorly correlated
+2.03%
More

RLFTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTY has been loosely correlated with RLFTF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTY jumps, then RLFTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTY
1D Price
Change %
RLFTY100%
-7.69%
RLFTF - RLFTY
43%
Loosely correlated
+5.56%
ORKA - RLFTY
23%
Poorly correlated
+1.65%
PCVX - RLFTY
21%
Poorly correlated
+5.68%
HOTH - RLFTY
21%
Poorly correlated
-0.14%
NERV - RLFTY
21%
Poorly correlated
-3.63%
More